Human Pathology
Volume 34, Issue 1 , Pages 65-73 , January 2003

Cell characterization of mononuclear and giant cells constituting pigmented villonodular synovitis

,Accepted 20 September 2002.

References 

  1. Jaffe HL, Lichtenstein L, Sutro CJ. Pigmented villonodular synovitis, bursitis, and tenosynovitis. Arch Pathol. 1941;31:731–765
  2. Darling JM, Goldring SR, Harada Y. Multinucleated cells in pigmented villonodular synovitis and giant cell tumor of tendon sheath express features of osteoclasts. Am J Pathol. 1997;150:1383–1393
  3. Rao AS, Vigorita VJ. Pigmented villonodular synovitis (giant-cell tumor of tendon sheath and synovial membrane): A review of eighty-one cases. J Bone Joint Surg Am. 1984;66:76–94
  4. Gehweiler JA, Wilson JW. Diffuse biarticular pigmented villonodular synovitis. Radiology. 1969;93:845–851
  5. Smith JH, Pugh DG. Roentgenographic aspects of articular pigmented villonodular synovitis. Am J Roentgenol. 1962;87:1146–1156
  6. Flendry F, Hughston JC. Pigmented villonodular synovitis. J Bone Joint Surg Am. 1987;69:942–949
  7. Flendry F, Hughston JC, McCann SB. Diagnostic features of diffuse pigmented villonodular synovitis of the knee. Clin Orthop Rel Res. 1994;298:212–220
  8. O'Connell JX, Fanburg JC, Rosenberg AE. Giant cell tumor of tendon sheath and pigmented villonodular synovitis: Immunophenotype suggests a synovial cell origin. Hum Pathol. 1995;26:771–775
  9. Tsang WYW, Chan JKC. KP1 (CD68) staining of granular cell neoplasms: Is KP1 a marker of lysosomes rather than the histiocytic lineage?. Histopathology. 1992;21:84–86
  10. Fujukawa Y, Sabokbar A, Neale S. Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis. Ann Rheum Dis. 1996;55:816–822
  11. Gravallese EM, Manning C, Tsay A, et al.  Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum. 2000;43:250–258
  12. Sabokbar A, Fujukawa Y, Neale S. Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells. Ann Rheum Dis. 1997;56:414–420
  13. Romas E, Bakharevski O, Hards DK, et al.  Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis. Arthritis Rheum. 2000;43:821–826
  14. Kullmann F, Judex M, Neudecker I, et al.  Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 1999;42:1594–1600
  15. El-Deiry WS, Tokino T, Velculescu VE, et al.  WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75:817–825
  16. Taniguchi K, Kohsaka H, Inoue N, et al.  Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis. Nat Med. 1999;5:760–767
  17. MacCallum DE, Hall PA. Biochemical characterization of pki67 with the identification of a mitotic-specific form associated with hyperphosphorylation and altered DNA binding. Exp Cell Res. 1999;252:186–198
  18. Katsuragi K, Chiba W, Matsubara Y, et al.  A sensitive and high-resolution method for the detection of mutations in the p53 gene using fluorescence-based PCR-SSCP. Biomed Res. 1995;16:273–279
  19. Tak PP, Klapwijk MS, Broersen SF, et al.  Apoptosis and p53 expression in rat adjuvant arthritis. Arthritis Res. 2000;2:175–178
  20. Yoneda J, Kuniyasu H, Crispens MA, et al.  Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J Nat Cancer Inst. 1998;90:447–454
  21. Nishikawa T, Ishikawa H, Yamamoto S, et al.  A novel calcitonin receptor gene in human osteoclasts from normal bone marrow. FEBS Lett. 1999;458:409–414
  22. Iino K, Sasano H, Oki Y. Urocortin expression in human pituitary gland and pituitary adenoma. J Clin Endocrinol Metab. 1997;82:3842–3850
  23. Montone KT, Brigati DJ. In situ molecular pathology. Instrumentation, oligonucleotides, and viral nucleic acid detection. J Histotechnol. 1994;17:195–201
  24. Sasano H, Uzuki M, Sawai T, et al.  Aromatase in human bone tissue. J Bone Miner Res. 1997;12:1416–1423
  25. Young JM, Hudacek AG. Experimental production of pigmented villonodular synovitis in dogs. Am J Pathol. 1954;30:799–811
  26. Yudoh K, Matsuno H, Nezuka T. Different mechanisms of synovial hyperplasia in rheumatoid arthritis and pigmented villonodular synovitis. Arthritis Rheum. 1999;42:669–677
  27. Alguacil-Galucia A, Unni KK, Goellner JR. Giant cell tumor of tendon sheath and pigmented villonodular synovitis: An ultrastructural study. Am J Clin Pathol. 1978;69:6–17
  28. Takeshita S, Kaji K, Kudo A. Identification and characterization of the new osteoclast progenitor with macrophage phenotype being able to differentiation into mature osteoclasts. J Bone Miner Res. 2000;15:1477–1488
  29. Lacey DL, Timms E, Tan H-L, et al.  Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93:165–176
  30. Yasuda H, Shima N, Nakagawa N, et al.  Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and identical to TRANCE/RANKL. Proc Natl Acad Sci U S A. 1998;95:3567–3602
  31. Tashiro H, Iwasaki H, Kikuchi M, et al.  Giant cell tumor of tendon sheath: A single and multiple immunostaining analysis. Pathol Int. 1995;45:147–155
  32. Blagosklonny MV, Schulte TW, Nguyen P, et al.  Taxol induction of p21WAF1 and p53 requires c-raf-1. Cancer Res. 1995;55:4623–4626
  33. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell. 1992;70:523–526
  34. Vega FJ, Iniesta P, Caldes T, et al.  p53 exon 5 mutations as a prognostic indicator of shortened survival in non–small-cell lung cancer. Br J Cancer. 1997;76:44–51
  35. Danks MK, Whipple DO, McPake CR, et al.  Differences in epitope accessibility of p53 monoclonal antibodies suggest at least three conformations or states of protein binding of p53 protein in human tumor cell. Cell Death Differ. 1998;5:678–686
  36. Thomas MD, McIntosh GC, Anderson JJ, et al.  A novel quantitative immunoassay system for p53 using antibodies selected for optimum designation of p53 status. J Clin Pathol. 1997;50:143–147
  37. Beroud C, Soussi T. p53 gene mutation: Software and database. Nucleic Acid Res. 1998;26:200–204
  38. Darling JM, Glimcher LH, Shortkroff S, et al.  Expression of metalloproteinases in pigmented villonodular synovitis. Hum Pathol. 1994;25:825–830
  39. Iwata Y, Mort JS, Tateishi H, et al.  Macrophage cathepsin L, a factor in the erosion of subchondral bone in rheumatoid arthritis. Arthritis Rheum. 1997;40:499–509
  40. Jackson CJ, Arkell J, Nguyen M. Rheumatoid synovial endothelial cells secrete decreased levels of tissue inhibitor of MMP (TIMP1). Ann Rheum Dis. 1998;57:158–161

☆ Supported in part by a grant-in-aid for Advanced Medical Science Research by the Ministry of Science, Education, Sports and Culture, Japan.

☆☆ Address correspondence and reprint requests to Takashi Sawai, MD, PhD, Department of Pathology, Iwate Medical University School of Medicine, 19-1 Uchimaru, Morioka, Iwate 020-8505, Japan.

PII: S0046-8177(03)00007-8

doi: 10.1053/hupa.2003.52

Human Pathology
Volume 34, Issue 1 , Pages 65-73 , January 2003

Article Tools

* Image Usage & Resolution